6 February 2026 The New York-based partner will advise biotech, pharma, and technology clients on patent prosecution, IP strategy and venture-backed transactions.
26 January 2026 The new recruit has a “stellar track record” of representing big tech in trade secret and patent litigation, and joins the firm’s newly opened San Francisco office.
22 January 2026 Orrick, Herrington & Sutcliffe adds senior litigators with experience in patent, trade secret, copyright, trademark, and commercial disputes across life sciences and technology.
16 January 2026 The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm.
14 January 2026 A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice.
14 January 2026 The US firm has recruited a European patent attorney with three decades of experience to build its patent prosecution offering across the continent.
